Maj Invest Equity
VC Fund
Copenhagen, Denmark
Maj Invest Equity is a VC fund in Copenhagen focused on Financial Services and Finance. Maj Invest is one of Denmark’s leading asset management companies, managing assets for primarily institutional clients. The Maj Invest group was established in 2005 and is today owned by employees, management and Danish institutional investors PKA, Realdania and PBU.The group comprises six companies: Maj Invest Holding A/S,Fondsmæglerselskabet Maj Invest A/S, Maj Invest Equity A/S and three companies related to international private equity funds. Click here for more information about their legal structure.They have two main business areas: Asset Management and Private Equity.In Asset Management they provide advice on strategic asset allocation and asset management of securities listed on regulated markets for institutional clients and the mutual funds Investeringsforeningen Maj Invest in Denmark and Maj Invest Funds in Luxembourg. They also offer wealth management services to wealthy individuals, companies and funds.Their Investor Relations & Markets department primarily handles Fondsmæglerselskabet Maj Invest A/S' client relations and supplies distributors with information on Investeringsforeningen Maj Invest and Maj Invest Funds.In Private Equity they act as advisors to private equity funds on their investments in unlisted equities in Denmark and abroad. In Denmark they advise four private equity funds and provide discretionary investment advisory services to clients on private equity portfolios. In the international part of their private equity business they advise three private equity funds on their investments in Vietnam, within microfinance and within energy and fertilizers.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 46%
- Fund size:
- $137M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Maj Invest Equity invests in
Stages Maj Invest Equity invests in
Countries Maj Invest Equity invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Series C
- $8.9M–$157M
- Series E
- $28M–$135M
- Venture - Series Unknown
- $3M–$74M
Investment Focus
Industry
- Financial Services 10 (36%)
- Finance 5 (18%)
- FinTech 4 (14%)
- Health Care 4 (14%)
- Biotechnology 4 (14%)
Stage
- Series C 5 (18%)
- Venture - Series Unknown 5 (18%)
- Series E 4 (14%)
- Series A 3 (11%)
- Funding Round 3 (11%)
Country
- India 10 (36%)
- Denmark 6 (21%)
- Indonesia 2 (7%)
- Israel 1 (4%)
- Norway 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jeppe Christiansen
Founder & Chief Executive Officer
|
Founder & Chief Executive Officer | Total investments: 3 | Find email | |
David A Paradiso
Partner
|
Partner | Total investments: 8 | Find email | |
|
Jeppe Christiansen
Founder & Chief Executive Officer
|
Founder & Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
SUBRA A/S
|
SUBRA A/S focuses on innovation, industrial-scale production, and creating a sustainable impact. | $46.9M / Series A / Apr 10, 2026 | |
Hemab
|
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threateningcomplications. | $157M / Series C / Oct 27, 2025 | |
Twin Health
|
Twin Health is a Metabolic Health platform combining Sensors, AI, and Medical Science to reverse chronic diseases and improve human metabolic health. They are backed by leading VC firms Iconiq Capital, Temasek, Sequoia Capital, Perceptive Advisors, Corner Ventures, LTS Investments, Helena, and Sofina with $249M in funding through Series D.Twinhas developed unique patent-pending technology (3 patents granted, 7 patents pending) to analyze complex biosignals from wearable sensors, predict metabolic outcomes using ML, and recommend highly-personalized treatments based on the metabolic profile of each patient. | $53M / Series E / Aug 21, 2025 | |
Dropla Tech
|
Dropla Tech develops drone and robotics technology intended for demining operations. The company's platform utilizes advanced AI systems and sensor fusion to scan the land and identify potential explosive hazards and accelerate mine clearance efforts, enabling clients to contribute to safer and more efficient land clearance efforts. | $2.8M / Pre-Seed / Aug 18, 2025 | |
MedGenome
|
MedGenome is a developer of sequencing genomics-based diagnostics and research platform intended to improve global health. The company's platform applies genomics technologies, bioinformatics, computing, and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eyedisorders, and other rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level. | $47.5M / Series E / Jul 21, 2025 | |
FlexiLoans
|
FlexiLoans is an online lending platform started with an endeavour to solve the problem that SMEs face in accessing Quick, Flexible and Adequate funds for growing their Businesses. Over 80% of Loan proposals from SMEs currently are rejected by institutional channels on account of inadequate financial history or collaterals. With the fast andubiquitous digital adoption in India and increased avenues to leverage data analytics, they are standing on the verge of Banking transformation in this country which will help us efficiently cater to the large untapped and unserved demand. They wish to make the ‘social and alternative scoring’ of SMEs and Individuals a big opportunity for the economy that will far out place the limited insights that financial bureau provide. They believe our technology-powered online marketplace is the best model to meet the financial requirements of SME’s who do not have credit history and hence cannot avail loans from traditional banking channels. | $43.9M / Series C / Jun 11, 2025 | |
Liva Healthcare
|
Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management.Winner of 'Health IT Firm of the Year' at the HealthInvestor Awards 2018 and 'Healthtech Innovators of the Year - Europe' at the Global Health & Pharma Awards 2018, Liva Healthcare is used by public healthcare,private insurance and pharma companies including NHS England and AXA PPP Healthcare.Liva Healthcare’s platform facilitates ongoing personalized health coaching through an intuitive app, building a strong bond between coach, GP, and patient. Its focus lies on tackling chronic illnesses, such as Type 2 diabetes, obesity, and heart disease by driving behavior change.The app is multilingual across several languages, proven to work efficiently across all socio-economic backgrounds, and is capable of engaging groups normally hard to reach. It is based upon nine to 18 months of continuous patient engagement to make new habits and behaviors stick. One coach can manage 500 patients per year simultaneously without the loss of patient outcomes.Implementation time from the get-go is normally within weeks and the platform is available as a white-label SaaS platform or as a turn-key solution, dependent on client specifications.Liva Healthcare has offices in Copenhagen, Denmark, and London, UK. | Venture - Series Unknown / Feb 05, 2025 | |
Finova Capital
|
They at FINOVA believe that by supporting and creating enabling opportunities for micro & small business, lives can be enriched & communities can be transformed. The company's aim is to reach out to financially excluded unorganized, Unreached MSME sector. The objective is to make finance available at a reasonable cost & deliver ina transparent manner.It stands for financial innovation. The company is headquartered in Jaipur & provides loan to both urban poor & rural poor to meet their productive requirements in starting new business or for growing an existing business.It is a young, growing company. | $135M / Series E / Oct 29, 2024 | |
|
FlexiLoans
|
FlexiLoans is an online lending platform started with an endeavour to solve the problem that SMEs face in accessing Quick, Flexible and Adequate funds for growing their Businesses. Over 80% of Loan proposals from SMEs currently are rejected by institutional channels on account of inadequate financial history or collaterals. With the fast andubiquitous digital adoption in India and increased avenues to leverage data analytics, they are standing on the verge of Banking transformation in this country which will help us efficiently cater to the large untapped and unserved demand. They wish to make the ‘social and alternative scoring’ of SMEs and Individuals a big opportunity for the economy that will far out place the limited insights that financial bureau provide. They believe our technology-powered online marketplace is the best model to meet the financial requirements of SME’s who do not have credit history and hence cannot avail loans from traditional banking channels. | $34.5M / Series C / Sep 10, 2024 | |
Amartha
|
Amartha is a financial technology company that connects micro and SME business partners with investors. | $17.5M / Venture - Series Unknown / Jun 18, 2024 | |
| See all 28 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Maj Invest Equity invest in?
Maj Invest Equity invests primarily in Financial Services, Finance and FinTech startups, most often at Series C and Venture - Series Unknown stage. Most of the 28 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Maj Invest Equity's check size?
Maj Invest Equity typically joins rounds of $8.9M–$157M at Series C, $28M–$135M at Series E and $3M–$74M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Maj Invest Equity participates in.
How do I contact Maj Invest Equity?
Public channels for Maj Invest Equity include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Maj Invest Equity?
The team at Maj Invest Equity includes Jeppe Christiansen (Founder & Chief Executive Officer), David A Paradiso (Partner) and Jeppe Christiansen (Founder & Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
